Average Out-of-Pocket Costs Without Insurance
Wegovy (semaglutide 2.4 mg for weight loss) and Ozempic (semaglutide 0.5-2 mg for diabetes) both carry high list prices around $1,350 per month before discounts or insurance. Without coverage, patients pay the full amount: about $1,300-$1,400 monthly for either, depending on dose and pharmacy. Ozempic's lower doses sometimes edge slightly cheaper at $1,200-$1,300, but the gap is minimal.[1][2]
With Insurance or Copay Cards
Commercial insurance often covers Ozempic more readily for type 2 diabetes, leading to copays of $25-$100 per month after deductibles. Wegovy coverage for weight loss is patchier—many plans exclude it or require prior authorization, pushing copays to $200-$500 or full price. Novo Nordisk's savings cards cap costs at $25/month for Ozempic (up to 13 fills) and $0-$150 for Wegovy (eligibility varies by insurance; max $225 savings quarterly). Uninsured patients qualify for up to $225 off Wegovy monthly via the card.[3][4]
| Scenario | Ozempic Copay | Wegovy Copay |
|----------|---------------|--------------|
| Good insurance (diabetes/weight loss approved) | $25-$100 | $100-$300 |
| Savings card eligible | $25/month | $0-$150/month |
| No coverage | $1,300-$1,400 | $1,350 |
Why Costs Differ and Factors Affecting Them
Ozempic gets priority reimbursement as a diabetes drug under medical necessity rules, while Wegovy's obesity indication faces stricter step therapy (try diet/exercise first). Prices spiked in 2023-2024 from demand and shortages. Pharmacy choice matters: Walmart or Costco can shave $50-$100 off cash price. State laws capping insulin don't apply here, but some mandate obesity drug coverage.[2][5]
Cheaper Alternatives or Ways to Lower Costs
Switch to compounded semaglutide (custom pharmacy versions) runs $200-$500/month, legal during shortages but riskier for quality. Compounded tirzepatide (Mounjaro/Zepbound copycat) starts at $300. Patient assistance programs like NovoCare offer free doses for low-income qualifiers (<400% federal poverty level). GoodRx coupons drop cash Ozempic to $900-$1,100, Wegovy to $1,100-$1,300. Medicare Part D covers Ozempic commonly but rarely Wegovy.[1][3][6]
When Generic or Biosimilar Competition Arrives
No generics yet—semaglutide patents run to 2031-2034, with Novo Nordisk defending against lawsuits. Exclusivity ends sooner for some doses, but biosimilars unlikely before 2026-2027 amid ongoing litigation. This keeps prices elevated; Teva and Hims & Hers are testing compounded entry points.[7]
[1]: GoodRx - Ozempic Pricing
[2]: GoodRx - Wegovy Pricing
[3]: NovoCare - Ozempic Savings
[4]: NovoCare - Wegovy Savings
[5]: Health Affairs - Semaglutide Coverage
[6]: Drugs.com - Compounded Semaglutide
[7]: DrugPatentWatch - Semaglutide Patents